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ORIGINAL ARTICLE
Pulse oximetry values of neonates admitted for care and receiving
routine oxygen therapy at a resource-limited hospital in Kenya
Melissa C Morgan ,1 Beth Maina,2* Mary Waiyego,2* Catherine Mutinda,2* Jalemba Aluvaala,3,4
Michuki Maina4 and Mike English4,5
1Department of Paediatrics, University of California San Francisco, San Francisco, California, United States, 2Department of Paediatrics, Pumwani Maternity
Hospital, 3Department of Paediatrics and Child Health, University of Nairobi, 4Kenya Medical Research Institute, Wellcome Trust Research Programme,
Nairobi, Kenya and 5Nufﬁeld Department of Medicine and Department of Paediatrics, University of Oxford, Oxford, United Kingdom
Aim: There are 2.7 million neonatal deaths annually, 75% of which occur in sub-Saharan Africa and South Asia. Effective treatment of hypoxaemia
through tailored oxygen therapy could reduce neonatal mortality and prevent oxygen toxicity.
Methods: We undertook a two-part prospective study of neonates admitted to a neonatal unit in Nairobi, Kenya, between January and
December 2015. We determined the prevalence of hypoxaemia and explored associations of clinical risk factors and signs of respiratory distress
with hypoxaemia and mortality. After staff training on oxygen saturation (SpO2) target ranges, we enrolled a consecutive sample of neonates
admitted for oxygen and measured SpO2 at 0, 6, 12, 18 and 24 h post-admission. We estimated the proportion of neonates outside the target
range (≥34 weeks: ≥92%; <34 weeks: 89–93%) with 95% conﬁdence intervals (CIs).
Results: A total of 477 neonates were enrolled. Prevalence of hypoxaemia was 29.2%. Retractions (odds ratio (OR) 2.83, 95% CI 1.47–5.47), nasal
ﬂaring (OR 2.68, 95% CI 1.51–4.75), and grunting (OR 2.47, 95% CI 1.27–4.80) were signiﬁcantly associated with hypoxaemia. Nasal ﬂaring (OR
2.85, 95% CI 1.25–6.54), and hypoxaemia (OR 3.06, 95% CI 1.54–6.07) were signiﬁcantly associated with mortality; 64% of neonates receiving oxy-
gen were out of range at ≥2 time points and 43% at ≥3 time points.
Conclusion: There is a high prevalence of hypoxaemia at admission and a strong association between hypoxaemia and mortality in this Kenyan
neonatal unit. Many neonates had out of range SpO2 values while receiving oxygen. Further research is needed to test strategies aimed at
improving the accuracy of oxygen provision in low-resource settings.
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What is already known on this topic
1 Out of range oxygen saturation (SpO2) levels may complicate
neonatal illness and lead to the development of retinopathy of
prematurity.
2 Effective monitoring and titration of oxygen therapy could
improve neonatal outcomes.
3 Shortages of nurses and pulse oximeters are common in low-
resource facilities.
What this paper adds
1 In a Kenyan neonatal unit, we found a high prevalence of hypox-
aemia at admission and a strong association between hypoxae-
mia and inpatient mortality.
2 Presence of nasal ﬂaring and hypoxaemia on admission were
signiﬁcantly associated with inpatient mortality.
3 Despite provision of contextually tailored training, many neonates
were outside the SpO2 target range while receiving oxygen therapy.
Globally, there are 2.7 million neonatal deaths annually.1 Pre-
term birth (<37 weeks gestation) is the leading cause of neonatal
death, three-quarters of which occur in sub-Saharan Africa and
South Asia,1 where availability of neonatal intensive care and
necessary equipment are limited. Hypoxaemia may complicate
neonatal illness and is reported to be common amongst sick neo-
nates admitted to paediatric wards in low- and middle-income
countries (LMICs, ranging from 17% to 43%).2–5 In The Gambia,
the mortality rate was 75% amongst neonates with hypoxemia,
which they deﬁned as oxygen saturation (SpO2) <90%.
2 Effective
treatment of hypoxaemia through tailored oxygen therapy could
reduce neonatal mortality in low-resource settings.
Pulse oximetry is the standard of care to non-invasively moni-
tor SpO2 in neonates in developed countries. This is particularly
important for preterm neonates, who are at risk for retinopathy
of prematurity (ROP).6–8 Globally, in 2010, an estimated 185 000
preterm infants developed ROP, and ~20 000 became blind or
severely visually impaired as a result.8 In high-income countries,
ROP is most common in infants born at <26 weeks.8 In LMICs,
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infants with severe ROP have a wider range of birthweights and
gestational ages, and rates of disease requiring treatment are
higher.7 ROP may occur even with non-invasive oxygen expo-
sure.9 Providers thus face a challenge to monitor and titrate oxy-
gen to provide the optimal ‘dose’.8,10,11 However, many LMIC
facilities do not have sufﬁcient nurses or oximeters to enable con-
tinuous monitoring of all neonates receiving oxygen.7,8,12,13 Addi-
tionally, guidelines and training on pulse oximetry are often
inadequate in low-resource settings.14
Several studies have investigated the proportion of time that
SpO2 was within the target range amongst preterm infants receiv-
ing oxygen.15–27 All studies except one were conducted in high-
income settings. These studies showed that, with manual titration,
SpO2 was outside and/or above the target range 18–84% and
15–58% of time, respectively.15–22,25,26 In Colombia, SpO2 was
within or above the target 34 and 55% of the time, respectively.21
Effects of training nurses to target SpO2 ranges are varied.
23,27
This study was conducted at Pumwani Maternity Hospital in
Nairobi, Kenya. We aimed (i) to determine the overall prevalence
of hypoxaemia in sick neonates admitted to the neonatal unit (Part
1) and (ii) to estimate the proportion of out of range SpO2 mea-
surements amongst neonates receiving oxygen therapy (Part 2).
Methods
Part 1: Determining prevalence of hypoxaemia
Setting
Pumwani Hospital is a maternity facility in Nairobi, located
~1800 m above sea level, which provides care to ~22 000 women
and their babies annually. A 60-bed neonatal unit provides care
for neonates requiring medical attention. There are 60–70 neo-
nates routinely being cared for by two to three nurses. Available
therapies include oxygen, continuous positive airway pressure
(CPAP), intravenous ﬂuids, antibiotics, phototherapy, nasogastric
feeds and medications for convulsions and apnoea. Mechanical
ventilation and oxygen blenders are not available.
Participants
Between January and December 2015, a consecutive sample of
‘sick’ neonates underwent pre- and post-ductal SpO2 testing at
admission before any oxygen was started. ‘Sick’ neonates were
those deemed to require management in the unit (other than
observation for low birthweight (LBW, <2.5 kg) and/or maternal
illness) by a physician or nurse. Eligible neonates were inborn or
transferred to Pumwani during the study period and admitted dur-
ing normal working hours. Neonates were excluded if transferred
for anomalies or severe medical problems within 4 h of birth.
Procedures
Measurements were obtained using Lifebox oximeters and neo-
natal probes, developed for low-resource settings by the World
Health Organization (WHO) and the World Federation of Socie-
ties for Anaesthesiologists (Acare Technology Co., New Taipei
City, Taiwan).28–30 Measurements were recorded only when
there was a good waveform and SpO2 was stable for ≥15 s. Medi-
cal ofﬁcers, who were trained on study objectives and procedures,
examined neonates and recorded gestational age, birthweight and
clinical signs of respiratory distress on admission. Disposition was
obtained from charts at the time of discharge or death. Gestational
age was based on last menstrual period (LMP), and Ballard exami-
nation was conducted when LMP was unknown or incongruent
with appearance (ultrasonography is rarely available). We deter-
mined the prevalence of hypoxaemia, calculated as the number of
neonates with pre- or post-ductal SpO2 below the previously
deﬁned local threshold of 89% for healthy term and preterm neo-
nates within 24 h at 1800 m,31 divided by the total number of
neonates admitted during the study period. We determined odds
ratios for hypoxaemia and all-cause inpatient death by gestational
age, birthweight and clinical risk factors and signs.
Part 2: Estimating proportion of SpO2
measurements outside target range
Participants
Over a 2-month period, between April and June 2015, a consec-
utive sample of neonates admitted for oxygen therapy were
enrolled. Neonates who were outborn, born outside the study
period or required transfer for anomalies or severe medical prob-
lems within 4 h of birth were excluded. Charts were tagged to
prevent concurrent enrolment in Part 1.
Sampling approach
SpO2 measurements were obtained at admission and four addi-
tional time points post-admission. To determine sample size, we
assumed a worst-case scenario that 50% of measurements would
be out of range. Using a conservative design effect of 2, a sample
size of 70 (with 280 post-admission measurements) provided an
effective sample size of 140, which would allow us to estimate a
proportion of out of range values of 50% with 95% conﬁdence
interval (CI) of 41–59%.
Target ranges
Based on the best available evidence to balance risks of ROP and
mortality at the time of this study,32–34 target ranges for term and
preterm neonates were established in collaboration with Kenyan
paediatricians and nurses, which advised values of SpO2 ≥ 92% for
neonates ≥34 weeks and SpO2 89–93% for neonates <34 weeks. A
training package was provided to staff prior to study implementa-
tion, which covered the use of the Lifebox and neonatal probe,29,30
target ranges and oxygen management using available resources.
Procedures
Using Lifebox oximeters and neonatal probes,28 trained nurses
obtained SpO2 values at 0, 6, 12, 18 and 24 h post-admission,
recording measurements only when there was a good waveform
and SpO2 was stable for ≥15 s. Due to limited resources (nurses,
oximeters), only post-ductal measurements were obtained. We
restricted the number of neonates being concurrently evaluated to
12 to ensure that one oximeter was available to guide therapy for
each neonate. When the total number of neonates being actively
evaluated reached 12, further enrolment was deferred until a neo-
nate exited this phase. Oxygen was delivered through nasal
prongs or masks (for CPAP) from an oxygen cylinder or concen-
trator. A ﬂow rate of 0.5 L (via nasal prongs) was used to com-
mence therapy, in line with WHO recommendations.35 Nurses
were advised to decrease oxygen slowly in a stepwise manner, as
tolerated, when SpO2 was above the target range or stable within
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the target range for an hour or more. When SpO2 was out of
range, additional data were prospectively collected, including
changes to ﬂow or mode of oxygen delivery, whether oxygen was
available and any additional therapies administered. When oxy-
gen was unavailable, reason(s) for lack of availability were
recorded, including lack of canisters, masks/prongs or other rea-
son. Gestational age was determined as above. We estimated the
proportion of out of range values with 95% CIs. Statistical ana-
lyses for both parts of this study were carried out using Stata V.13
(StataCorp, College Station, TX, USA).
Ethical aspects
All participants received standard care as clinically indicated and
available. Following an explanation about the study by a research
nurse who spoke the appropriate language, written informed
consent was obtained from a parent/guardian. Ethical approval
was received from the University of California, San Francisco and
the Kenya Medical Research Institute.
Results
Part 1
A total of 407 neonates were consecutively enrolled between
January and December 2015. All eligible neonates were enrolled.
The median gestational age was 39 weeks (10th–90th percentile
range 32–40), median chronological age was 1.8 h (10th–90th
percentile range 0.2–29.9), median birthweight was 3.0 kg (10th–
90th percentile range 1.8–3.6), 54.3% were male, and 61.4%
were delivered vaginally. Hypoxaemia (SpO2 < 89%) was present
in 119 neonates (29.2%, 95% CI: 24.9–33.9). Fifty-four (13.3%)
neonates died during the study period (all-cause mortality).
Fully adjusted odds ratios (aORs) for hypoxaemia and mortal-
ity by clinical risk factors and signs are displayed in Table 1.
Retractions (OR 2.83, 95% CI 1.47–5.47), nasal ﬂaring (OR 2.68,
95% CI 1.51–4.75) and grunting (OR 2.47, 95% CI 1.27–4.80)
on admission were signiﬁcantly associated with hypoxaemia.
Flaring (OR 2.85, 95% CI 1.25–6.54) and hypoxaemia (OR 3.06,
95% CI 1.54–6.07) on admission were signiﬁcantly associated
with mortality.
Part 2
Seventy neonates were consecutively enrolled between April and
June 2015. All eligible neonates were enrolled. The median ges-
tational age was 38 weeks (10th–90th percentile range 30–40),
median chronological age was 3.4 h (10th–90th percentile range
0.6–72.6), median birthweight was 2.8 kg (10th–90th percentile
range 1.4–3.7), 64.3% were male, and 62.9% were delivered
vaginally. Sixty-four percent of neonates were out of range at ≥2
time points and 43% at ≥3 time points in the ﬁrst 24 h. Table 2
shows the frequency and proportion of all neonates and preterm
and/or LBW neonates by the number of times they were out of
range over the ﬁrst 24 h.
Figure 1 shows the proportion of neonates above and below
target, and the total proportion out of range at each time point.
Two neonates, both term and >3 kg, remained persistently hypox-
aemic (<89% at all time points) despite provision of increasing
ﬂow, antibiotics and other therapies. CPAP was not available for
either of these neonates. Figure 2 shows the proportion of preterm
and/or LBW neonates above and below target and the total pro-
portion out of range. The overall range of SpO2 values outside the
target range was 33–100%. Only six hyperoxaemic neonates (all
preterm) and three hypoxaemic neonates (all term) were ≤3
points outside the target range at a single time point.
When SpO2 was below target, ﬂow was increased in 59%,
oxygen was restarted in 5%, and CPAP was started in 4%. In
32% of cases, no action was taken. When SpO2 was above target,
ﬂow was decreased in 25%, and no action was taken in 75%.
Oxygen was unavailable twice in the 350 time points assessed.
Masks and nasal prongs were available at all time points. Thus,
lack of access to basic resources was not a problem; however,
availability of CPAP was limited.
Discussion
This study demonstrates that 29.2% of neonates were hypoxae-
mic upon admission to a neonatal unit in Nairobi, which predom-
inately cares for newborns delivered in the facility and admitted
within 24 h of birth. This is higher than the prevalence of neona-
tal hypoxaemia reported in Kiliﬁ, Kenya (23%)3 and The Gambia
(16.5%)2 but lower than reported in India (38.5%)4 and Papua
New Guinea (43%).5 Taken together, these data suggest a high
burden of neonatal hypoxaemia.
Table 1 Adjusted odds ratios (AOR) for hypoxaemia and mortality by clinical risk factors and signs of respiratory distress (n = 407)
Hypoxaemia Mortality
n (%) n (%) AOR† 95% CI P value n (%) AOR‡ 95% CI P value
Low birthweight (<2.5 kg) 99 (24.3) 43 (43.4) 0.71 0.30–1.72 0.450 23 (23.2) 1.36 0.45–4.13 0.584
Prematurity (<37 weeks) 87 (21.4) 42 (48.3) 1.44 0.58–3.61 0.432 21 (24.1) 0.69 0.21–2.24 0.534
Retractions 248 (60.9) 103 (41.5) 2.83 1.47–5.47 0.002 49 (19.8) 2.05 0.68–6.16 0.200
Nasal ﬂaring 140 (34.4) 76 (54.3) 2.68 1.51–4.75 0.001 41 (29.3) 2.85 1.25–6.54 0.013
Grunting 87 (21.4) 53 (60.9) 2.47 1.27–4.80 0.008 30 (34.5) 2.23 0.98–5.06 0.055
Hypoxaemia 119 (29.2) 36 (30.3) 3.06 1.54–6.07 0.001
†Adjusted for low birthweight, prematurity, retractions, nasal ﬂaring and grunting. ‡Adjusted for low birthweight, prematurity, retractions, ﬂaring, grunt-
ing and hypoxaemia. CI, conﬁdence interval.
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In low-resource settings, where availability of pulse oximeters
may be limited, use of clinical signs to guide decision making is
essential. In our study, retractions, nasal ﬂaring or grunting on
admission were signiﬁcantly associated with hypoxaemia. A
study in Papua New Guinea also found grunting was signiﬁcantly
associated with hypoxaemia,5 while one in Kenya found that
ﬂaring or retractions were signiﬁcantly associated only in univari-
ate analysis.36 In our study, ﬂaring was signiﬁcantly associated
with mortality, and adjusted odds of mortality were increased
three-fold in hypoxaemic neonates. This is congruent with stud-
ies in The Gambia, Kenya and Papua New Guinea, which found
odds or relative risk of death increased by 7.7, 4.3 and 3.1 times,
respectively.2,5,36 In our study, death occurred despite availability
of basic oxygen delivery devices, but with limited availability of
CPAP and lack of mechanical ventilation and oxygen blenders.
Periods of hypoxaemia and hyperoxaemia can cause vasocon-
striction with subsequent abnormal retinal vascular growth, lead-
ing to ROP even in the absence of invasive ventilation.8,9 Despite
several large randomised trials,32–34 the optimal SpO2 range to
reduce risk of ROP, while optimising survival, remains unclear. A
recent post-hoc analysis of data from two trials found that a tar-
get range of 85–89%, versus 91–95%, resulted in signiﬁcantly
increased risks of death or disability at 2 years and death alone.37
The WHO recommendations state that SpO2 should be ≥88% for
all newborns in the ﬁrst hours of life and, additionally, ≤95% for
preterm neonates,35 similar to the target range for preterm neo-
nates in this study. Beyond the ﬁrst hours, the WHO recom-
mends that oxygen be commenced for SpO2 ≤ 90%. The latter
recommendation is supported by the combined trial analysis37
and a recent systematic review.38
Table 2 Frequency of out of range oxygen saturation (SpO2) measurements amongst neonates receiving oxygen therapy in the ﬁrst 24 h of admission (n = 70)
Number of times outside
target range†
Frequency of all
neonates (n = 70), n (%) 95% CI
Frequency of preterm
and/or LBW neonates (n = 30), n (%) 95% CI
0/5 9 (12.9) 6.1–23.0 2 (6.7) 0.8–22.1
1/5 16 (22.9) 13.7–34.4 5 (16.7) 5.6–34.7
2/5 15 (21.4) 12.5–32.9 7 (23.3) 9.9–42.3
3/5 14 (20.0) 11.4–31.3 7 (23.3) 9.9–42.3
4/5 7 (10.0) 4.1–19.5 7 (23.3) 9.9–42.3
5/5 9 (12.9) 6.1–23.0 2 (6.7) 0.8–22.1
SpO2 < 92% for neonates ≥34 weeks gestation. SpO2 < 89% or >93% for neonates <34 weeks gestation. †Measurements obtained at time of admission
and at 6, 12, 18 and 24 h post-admission. CI, conﬁdence interval; LBW, low birthweight.
Fig. 1 Proportion of neonates outside oxygen saturation target range
over the ﬁrst 24 h of admission. The total proportion of neonates outside
the target range decreased from 61% at hour 0 to 58% at hour 6 and 37 to
38% at hours 12, 18 and 24. At hour 0, 31% were above and 30% were
below the target range. More neonates were above the target on oxygen
therapy from hour 6 onwards. ( ), Above target; ( ), below target;
( ), total proportion out of range.
Fig. 2 Proportion of preterm and/or low birthweight neonates outside
oxygen saturation target range over the ﬁrst 24 h of admission. The total
proportion of preterm and/or low birthweight (LBW) neonates outside
the target range decreased from 50% at hour 0 to 43% at hours 6, 12 and
18 and 40% at hour 24. More preterm and/or LBW neonates were above
the target on oxygen therapy at all time points, ranging from 37% at
hours 0 and 24–40% at hours 6 and 18 and 43% at hour 12. ( ), Above
target; ( ), below target; ( ), total proportion out of range.
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In Part 2, 43% of all neonates and 53% of preterm and/or
LBW neonates were out of range at ≥3 time points in the ﬁrst
24 h. In a trial of 20 non-invasively ventilated neonates <1000 g
in Colombia, the proportion of time within target range was
33.7  4.7% amongst those receiving manual titration.21 In our
study, 37–43% of preterm and/or LBW neonates were above the
target at all time points, higher than one study (25%),22 but
lower than two others (55–58%).19,21 Notably, only one of these
studies was conducted in an LMIC. Generalising results from
high-income to LMIC settings is problematic.39
We did not consider lack of access to pulse oximeters, oxygen
and masks/cannulas major factors during this study, which sup-
plied oximeters. Lack of nursing action in response to the high
proportion of out of range values was common. This may reﬂect
high workload and patient-to-nurse ratio and the limited range
of options available to nurses in this unit. In a high-income set-
ting, time inside the target range decreased and time above
increased with patient-to-nurse ratio ≥3.26 Other potential causes
include inappropriate implementation or insufﬁcient training,
related to limited baseline knowledge amongst nurses and spar-
sity of data in low-resource settings. Further research is needed
to explore strategies aimed at improving oxygen targeting in such
settings, where nurses care for many neonates and knowledge is
generally low.
This study has limitations. It is possible that prevalence results
may have been inﬂuenced by training in Part 2. However, this is
unlikely as measurements were obtained at admission before any
oxygen was started. In Part 1, the 10th percentile of chronologi-
cal age was 0.2 h (12 min); thus, a small proportion of the
hypoxaemic measurements may reﬂect normal adaptive physiol-
ogy. Our ﬁndings for Part 2 are based on a sample of 70 neonates,
among which 30 were preterm and/or LBW, 12 were very pre-
term (<32 weeks), and 7 were very LBW (<1.5 kg). Our results
suggest that oxygen titration may be more challenging in smaller,
more preterm neonates; however, our sample is too small to
draw any speciﬁc conclusions. As ultrasonography is rarely avail-
able in this population, we determined gestational age using LMP
or Ballard examination. In Bangladesh and Papua New Guinea,
mean difference between reference ultrasound and Ballard were
−2.8 and 6 days, respectively,40,41 and mean difference between
ultrasound and LMP was 3 days.41 The Lifebox oximeter is not
motion-resistant and has not been validated in neonates. To
obtain the most accurate measurements possible, we recorded
SpO2 only when there was a good waveform and SpO2 was sta-
ble for ≥15 s. The Lifebox does not enable continuous recording
of SpO2, which limits direct comparison of our ﬁndings to related
studies in high-resource settings. In Part 2, we only measured
post-ductal SpO2 due to resource limitations. Studies have dem-
onstrated that pre-ductal SpO2 is higher in the ﬁrst 4 h
42–44 but
becomes equal to post-ductal SpO2 by 18–24 h.
45,46 Post-ductal
measurements were obtained at all time points, and ≥50% of
neonates were above target at all time points; thus, we do not
believe this affected our results.
Seven studies reported that use of automated oxygen control
devices, which compare incoming SpO2 readings with a desired
value, increased the proportion of time inside the target range
compared to manual titration.15–17,20–22 While promising, such
devices are unlikely to be available in low-resource settings in
the near future. Additional strategies for improved oxygen
targeting are needed for these settings, where nurses are few and
workload is high.47,48 Furthermore, wider availability of pulse
oximeters in facilities is essential. In 2012, only 4 of 22 Kenyan
training hospitals had functional pulse oximeters.49 Oxygen pro-
vision may be improved through enhanced nurse training,
including multiple ‘doses’ over time; increased numbers of neo-
natal nurses; and training mothers, who often participate in the
care of their babies in low-resource facilities, to titrate oxygen
with supervision. A study assessing the effects of a parent training
programme for infants being discharged home on oxygen found
that those who received training had signiﬁcantly improved post-
test scores.49 Employment of trained care facilitators and develop-
ment of simple SpO2 monitors with algorithm-based instructions
to support mothers could also be beneﬁcial.
Conclusion
There is a high prevalence of hypoxaemia at admission and a
strong association between hypoxaemia and inpatient mortality
in this Kenyan neonatal unit, indicating the need for wider
deployment of pulse oximeters to LMICs. Despite the provision of
a contextually tailored training package, many neonates receiving
oxygen were outside the SpO2 target range. Further research is
needed to test strategies aimed at improving accuracy of oxygen
provision in low-resource settings.
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